About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, November 23rd, 2016

The QualityStocks
Daily Stock List


Boston Therapeutics, Inc. (BTHE)

Wall Street Mover, RedChip, TaglichBrothers, Stock News Now, TopPennyStockMovers, SmallCapVoice, PennyStocks24, and MissionIR reported earlier on Boston Therapeutics, Inc. (BTHE), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Boston Therapeutics, Inc. is a developer of complex carbohydrate therapeutics to treat diabetes and inflammatory diseases. The Company’s product pipeline centers on developing and commercializing therapeutic molecules that address diabetes and inflammatory diseases. The Company also developed and markets SUGARDOWN®. This is a non-systemic, complex carbohydrate-based dietary food supplement. The design of SUGARDOWN® is to support healthy blood glucose. Boston Therapeutics is based in Lawrence, Massachusetts.

The Company’s product pipeline includes BTI-320. This is a non-systemic, non-toxic, chewable complex carbohydrate-based compound. The design of it is to reduce post-meal glucose elevation. BTI-320 is a proprietary polysaccharide. BTI-320 works in the gastrointestinal tract to block the action of carbohydrate-hydrolyzing enzymes, which break down complex carbohydrates into simple sugars, lessening the availability of glucose for absorption into the bloodstream.

Boston Therapeutics entered a clinical trial agreement with Joslin Diabetes Center to be the lead clinic in a Phase II study of BTI-320. In addition, Boston Therapeutics’ product pipeline includes IPOXYN™. This is an injectable anti-necrosis drug. The design of it initially is to treat lower limb ischemia associated with diabetes.

Furthermore, Boston Therapeutics’ product pipeline includes OXYFEX™. This product can serve as the only available oxygen delivery mechanism for animals suffering ischemia or traumatic and surgical blood loss events. OXYFEX™ is the Company’s veterinary facsimile to IPOXYN™.

In 2015, Boston Therapeutics announced that its affiliate, Advance Pharmaceutical, initiated the SUGARDOWN® clinical trial in Hong Kong. Advance Pharmaceutical is evaluating the effect of SUGARDOWN® on Post-Prandial Hyperglycemia in Chinese subjects with Pre-Diabetes. The lead clinical site is the Department of Medicine, The Chinese University of Hong Kong (CUHK), Prince of Wales Hospital.

Advance Pharmaceutical is conducting the above-mentioned clinical trial at CUHK to evaluate BTI-320 in subjects who are pre-diabetic. The interim clinical analysis in the proof of concept trial demonstrate up to 77 percent reduction in Glucose and up to 27 percent in Fructose.

Boston Therapeutics released in December 2015 final trial results from its proof of concept (POC) Sydney University study. The study showed consumption of SUGARDOWN® tablets before sugary beverages was found to substantially decrease the postprandial glucose, fructose, and insulin responses to the sugary soft drink beverage. Every subject had a favorable response.

Last month, Boston Therapeutics and Advance Pharmaceutical presented the positive topline data on postprandial hyperglycemia in high risk pre-diabetic Chinese population from the proof of concept trial (Protocol Code: SG01) conducted at CUHK.

Positive Phase II Data supports the effect and safety of BTI-320 in a randomized, double-blind, placebo controlled clinical trial. With greater than 95 percent overall compliance across study groups, the Phase II Proof Of Concept Trial demonstrated that low dose (4g) and high dose (8g) BTI-320 are safe and effective in considerably lessening various continuous glucose monitor (CGMS) parameters versus placebo.

Also, last month, Boston Therapeutics and Advance Pharmaceutical announced another advancement in the development of its investigative materials (BTI-320). The Research and Development Cash Rebate Program of up to $400,000 (USD) from the Hong Kong Innovation and Technology Commission (ITC), received by a subsidiary of Advance Pharmaceutical will be used for a feasibility study of a novel way to safely and accurately self-screen and facilitate risk management associated with the onset of diabetes and other vascular disease-related states.

Boston Therapeutics, Inc. (BTHE), closed Wednesday's trading session at $0.1245, down 0.40%, down 24,676 volume with 6 trades. The average volume for the last 60 days is 12,608 and the stock's 52-week low/high is $0.033/$0.17.

Bang Holdings Corp. (BXNG)

Promotion Stock Secrets reported this month on Bang Holdings Corp. (BXNG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bang Holdings Corp. is a digital advertising company listed on the OTCQB. It provides brand management, cannabis related digital content and influencer-based marketing for the cannabis industry. The Company does all of this through its subsidiary, Bang Digital Media. Bang Holdings’ marketing networks enables companies to directly reach cannabis and cannabis equipment consumers. Bang Holdings went public in March 2016.

Bang Holdings is strategically building a digital advertising network that connects cannabis brands to consumers. Since launching its digital channel 4TwentyToday across multiple digital platforms in 2014, Bang Digital Media’s network has increased to over a million engaged enthusiasts. Moreover, it has produced hundreds of millions of content views. Its expanded network of cannabis-friendly social influencers reaches an additional twenty million subscribers.  

Bang Holdings’ plan is to ramp up Bang Digital Media’s growth of its social network and content views. These represent the Company’s pre-revenue Key Performance Indicator (KPI).  Bang Digital Media is moving ahead with advances in digital technology marketing applications. Presently, it is in the development of the first genuine DSI (Digital Social influencer).  DSI’s can work as original characters, mascots, or spokespersons for a product.  Alternatively, DSI’s can be utilized to enhance the online presence of a celebrity influencer.

Bang Holdings is aggressively targeting the huge cannabis advertising void created by Google, whose restrictive advertising policies prohibit cannabis-related companies. The advertising policies of Google, and Yahoo and others, hugely restrict cannabis companies from advertising online. Furthermore, they do not permit mainstream corporations to specifically target the cannabis market.

In October, Bang Holdings, via Bang Digital Media, announced it created the globe’ first Artificial Intelligence (A.I.) personality to sell products to humans through Facebook Messenger. This is without the customer ever realizing they are speaking to a chatbot.

Earlier this month, Bang Holdings, through Bang Digital Media, announced its “Donald Bot” is delivering notable real-world productivity test-market results. The Company said that this proves A.I. bot technology could render human staffed call centers obsolete. During Week One of market beta-testing, 5.7 percent of The Donald Bot’s 776 conversations on Facebook resulted in sales. The Company said that this indicates that the bot’s closing ratio compares favorably to results attained in call centers staffed by humans.

Last week, Bang Holdings, via its Bang Digital Media, announced it believes that laws legalizing recreational cannabis use in California, Massachusetts, Maine and Nevada, along with medical marijuana initiatives passed in Montana, Florida, Arkansas, and North Dakota are game changers for its business, and that of its clients.

Bang Holdings Corp. (BXNG), closed Wednesday's trading session at $2.00, up 8.11%, on 3,231 volume with 12 trades. The average volume for the last 60 days is 1,677 and the stock's 52-week low/high is $0.99/$4.00.

Calmare Therapeutics, Inc. (CTTC)

TaglichBrothers, OTCBB Journal, and SmallCapVoice reported previously on Calmare Therapeutics, Inc. (CTTC), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Calmare Therapeutics, Inc. (the Calmare Pain Mitigation Therapy™ company) researches, develops, and commercializes chronic, neuropathic pain, and wound affliction devices. Calmare devices sell commercially to medical practices around the world. Additionally, they are found in U.S. military hospitals, clinics, and on installations via the Company’s General Services Administration (GSA) military contract (V797P-4300B). Calmare Therapeutics has successfully licensed greater than 500 technologies to over 400 individual organizations. Calmare Therapeutics is headquartered in Fairfield, Connecticut.

Calmare’s flagship medical device is the Calmare® Pain Therapy Device. This is the world's only non-invasive and non-addictive modality, which can successfully treat chronic, neuropathic pain. The Company holds a U.S. Food & Drug Administration (FDA) 510k clearance designation (K081255) on its flagship device. This grants it the exclusive right to sell, market, research, and develop the medical device in the United States.

Pertaining to CALMARE® Pain Therapy Treatment, the device is FDA-cleared for U.S. sales, U.S. patented and patent pending in other countries, and medically certified in Europe. The Calmare® Pain Therapy Device treats oncologic and neuropathic pain through a biophysical rather than biochemical approach.

Calmare Therapeutics’ medical devices provide a non-pharmacological (no drugs), non-addictive (no narcotics) and non-invasive (over the skin) solution to chronic pain sufferers in an outpatient treatment setting. The Company supplements its medical devices with a catalogue of private label neurostimulation and sensory electrodes.

Calmare creates partnerships with its clients and customers to maximize their Intellectual Property (IP) assets, decrease time-to-market, and add to their profitability. Calmare’s Technology Sourcing Service looks for technologies that fit with customer business objectives and presents them as potential licensing or IP acquisition candidates.

Since 2010, Calmare Therapeutics has been a preferred vendor of the U.S. federal government (GSA#V797P-4300b). Devices, consumables and related hardware sell to U.S. military hospitals and clinics across the U.S. The Company sells its devices in Europe under CE-mark designation, which was issued by the European Commission’s Competitiveness and Innovation Program in 2010.

Calmare Therapeutics, Inc. (CTTC), closed Wednesday's trading session at $0.202, up 67.63%, on 35,188 volume with 11 trades. The average volume for the last 60 days is 20,515 and the stock's 52-week low/high is $0.10/$0.36.

Pacific Office Properties Trust, Inc. (PCFO)

TopPennyStockMovers and Real Pennies reported previously on Pacific Office Properties Trust, Inc. (PCFO), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Pacific Office Properties Trust, Inc. is a Real Estate Investment Trust (REIT) whose shares trade on the OTC Markets’ OTCQB. The Company is an externally advised REIT that owns and operates institutional quality office properties in Hawaii and Phoenix, Arizona. Pacific Office Properties Trust has its corporate headquarters in Honolulu, Hawaii.

The Company’s advisor is Shidler Pacific Advisors, LLC. This is an entity owned and controlled by Mr. Jay H. Shidler, Pacific’s Chairman of the Board. Mr. Lawrence J. Taff, the Company’s President, Chief Executive Officer, Chief Financial Officer and Treasurer, also serves as President of Shidler Pacific Advisors. Shidler Pacific Advisors is responsible for the daily operation and management of the Company. This includes management of its wholly-owned properties.

Pacific Office Properties Trust receives income primarily from rental revenue (including tenant reimbursements) from its office properties and, to a lesser degree, from its parking revenues. Its office properties are usually leased to tenants with good credit for terms ranging from two to 20 years.

As of December 31, 2015, Pacific Office Properties Trust’s property portfolio comprised seven institutional quality office buildings consisting of 2.0 million rentable square feet. Primarily Class “A” assets, most the Company’s properties are situated in supply-constrained submarkets with high barriers to entry and robust real estate fundamentals.

As at December 31, 2015, the Company’s property portfolio included office buildings in Honolulu and Phoenix. In Honolulu, its portfolio includes:

- Davies Pacific Center - Central Business District (a 22-story office property with an attached garage and ground floor retail space)

- Pacific Business News Building

- Kapiolani (a 10-story, office building located at the entrance to the Waikiki district of Honolulu)

- Pan Am Building - Kapiolani (a 17-story, Class A office building with an integral parking garage and ground floor retail shops and services)

- Waterfront Plaza -  Central Business District (a Class A office complex set among a finely landscaped 8.7-acre campus in Honolulu's Central Business District)

In Phoenix, its property portfolio includes City Square in the Central Business District/North Central. The City Square Office Towers are part of the largest mixed use-commercial condominium in the State of Arizona. Further to its three office towers, the complex includes a 156-room Hilton Garden Inn, and a 35,000-square foot Sports Club located on 16 acres in mid-town Phoenix.

Pacific Office Properties Trust, Inc. (PCFO), closed Wednesday's trading session at $0.11, down 26.67%, on 6,100 volume with 3 trades. The average volume for the last 60 days is 6,991 and the stock's 52-week low/high is $0.05/$1.75.

Cyalume Technologies Holdings, Inc. (CYLU)

SmallCapVoice and SeriousTraders reported previously on Cyalume Technologies Holdings, Inc. (CYLU), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cyalume Technologies Holdings, Inc. manufactures and sells chemiluminescent products, and reflective and photoluminescent materials. It sells these products to the military, ammunition, and commercial and public safety markets in the U.S. and globally. Cyalume is the sole supplier of chemical light to the U.S. military and other world-class organizations around the world.

The Company previously went by the name Vector Security Intersect Acquisition Corp. It changed its corporate name to Cyalume Technologies Holdings, Inc. in December of 2008. The Company has its head office in Fort Lauderdale, Florida. It has manufacturing and distribution for chemical light, ammunition, and commercial chemical products that serve North and South America and Asia located in West Springfield, Massachusetts.

Cyalume Technologies is the world leader in chemical light solutions. It provides light sticks, chemi-luminescent ammunition, and also infra-red devices. In addition, the Company is a Food and Drug Administration (FDA) approved manufacturer of API components for the pharmaceutical industry and produces complex long chain polymers used in a broad assortment of final applications. These range from the F35 Joint Strike Fighter to a coating for implantable medical devices.

Cyalume Specialty Products, Inc. is based in Bound Brook, New Jersey. It manufactures and distributes products for the pharmaceutical, medical products, and cosmetics industry.

Cyalume Technologies SAS (in the South of France in Aix-en-Provence near Marseille) manufactures and distributes for Europe, the Middle East and Africa. This includes diverse chemical light products, tactical training equipment and devices, and certain chemical formulations.

Cyalume Technologies’ ChemLight and SnapLight brands have a reputation for brightness and reliability. Regarding Industrial applications, the Company’s chemical light technologies are utilized by mining, manufacturing and other industries where a safe and reliable light source is imperative.

Cyalume provides emergency lights to hospitals, hotels, schools, as well as other facilities. The Company also provides ammunition. It has its Training & Tactical Ammunition. This is the world's first 40 mm non-pyrophoric, non-dud producing training round.

Cyalume Technologies Holdings, Inc. (CYLU), closed Wednesday's trading session at $0.11, even for the day, on 112,800 volume with 4 trades. The average volume for the last 60 days is 20,344 and the stock's 52-week low/high is $0.03/$0.15.


The QualityStocks
Company Corner


OurPet's Company (OPCO)

The QualityStocks Daily Newsletter would like to spotlight OurPet's Company (OPCO). Today, OurPet's Company closed trading at $1.00, up 8.11%, on 7,500 volume with 9 trades. The stock’s average daily volume over the past 60 days is 5,248, and its 52-week low/high is $0.6882/$1.06.

OurPet's Company today, was announced among the agenda for the upcoming VirtualInvestorConferences.com, the evergreen online investor conference series. Individual investors, institutional investors, advisors, and analysts are invited. The show opens on at 9:00 AM ET, with the first live webcast at 9:15 AM ET, on Thursday, December 1. Dean Tsengas, COO, and Scott Mendes, CFO, will present live at VirtualInvestorConferences.com on December 1, 2016.

OurPet's Company (OPCO) develops, produces and markets various pet accessory and consumable products designed to awaken pets' natural instincts, be it in feeding, playing or waste management. Sold globally through pet specialty retailers, food, drug and mass chains, e-commerce and international channels, the company's products are marketed under a the OurPets®, Pet Zone® and PetTastic® brands with well-known sub-brands such as Play-N-Squeak™, Cosmic Catnip™, Durapet, SmartScoop and Flappy. In total, OurPet's has an intellectual property portfolio featuring more than 160 individual patents, giving the company sustainable access to the pet products industry for the foreseeable future.

In recent years, the U.S. pet products and services market has experienced strong growth, with total sales accounting for approximately $73 billion in 2014, according to a report by Packaged Facts. In 2015, this strong performance is expected to continue, building on the recent rise in related ecommerce purchases, as well as an uptick in dog and cat ownership throughout the country. In order to capitalize on this market performance, OurPet's maintains an ongoing new product development program to continually keep an evolutionary and revolutionary new product pipeline feeding its offerings. In July 2015, OurPet's introduced many new products at the national Super Zoo trade show in Las Vegas such as the Catty Whack®, Designer Diner™/Barking Bistro™ and the Zoom Plume™.

The company's capitalization strategy is guided by a management team of experienced industry professionals dedicated to further strengthening its product portfolio through aggressive development of innovative products. Management has a proven track-record of leveraging deep knowledge in the innovation, technology, distribution and pet markets to successfully push through adverse market conditions to achieve increases in revenue, margins and net income.

OurPet's, through its innovative and extensive line of popular pet products, is in a favorable strategic position to continue building upon its recent market growth. For prospective shareholders, this positioning makes the company an intriguing investment opportunity in the months to come. Look for OurPet's to capitalize on steady market performance moving forward, providing an opportunity for the company to realize strong investor returns in the future. Disclaimer

OurPet's Company Company Blog

OurPet's Company News:

OurPet's Company to Webcast, Live, at VirtualInvestorConferences December 1

OurPet’s Company Reports Record Third Quarter 2016 Results

OurPet's Company CFO to Present at the MicroCap Conference in Philadelphia

Moxian, Inc. (MOXC)

The QualityStocks Daily Newsletter would like to spotlight Moxian, Inc. (MOXC). Today, Moxian, Inc. closed trading at $3.47, off by 8.44%, on 28,847 volume. The stock’s average daily volume over the past 60 days is 2,553, and its 52-week low/high is $3.41/$10.50.

Moxian, Inc. Management from Moxian, Inc. ("Moxian" or the "Company") (NASDAQ: MOXC), an offline-to-online (O2O) integrated social media platform operator, is currently in New York City to ring the opening bell and signal the start of today's trading for NASDAQ. From the Nasdaq MarketSite in Times Square, Moxian chairman and CEO James Tan, along with Executive Director Hao Qing Hu, will ring the bell in honor of the Company's recent uplist to the NASDAQ Capital Market. “We are honored to open the day's trade and celebrate Moxian's advancement to the NASDAQ exchange," says Tan. "This achievement reflects the hard work of everyone at Moxian as we pursue opportunities to grow corporate and shareholder value."

Moxian, Inc. (MOXC) engages in the business of providing social marketing and promotion platforms designed to help merchants accelerate and advertise their business growth through social media. These products and services enable merchants to run targeted advertising campaigns and promotions, and aim to enhance the interaction between users and merchant clients by using consumer behavior data compiled from the Moxian database of user activities. The company has two primary core products: Moxian+ User App and Moxian+ Business App.

Developed in Shenzhen, China, Moxian integrates social media, entertainment and business intelligence. The Multi-Channel Social Commerce Platform, which includes a variety of tools such as Moxian's proprietary Social Customer Relationship Management (SCRM) system, generates knowledgeable data for merchants. This way, consumers and businesses are able to connect and interact with one another to achieve the concept of "online lifestyle, offline fun."

Moxian+ User App serves as an App driven for consumer users to use the platform, consisting of our proprietary virtual currency (MO-Coin and MO-Points), social networking, redemption centre and game centre. Users can earn MO-Coins by playing games, and then use those coins to redeem prizes sponsored by Moxian and client merchants. This model not only drives registered consumers to Moxian and merchant, but also provides merchants the opportunity to advertise, run marketing campaigns, and learn about their customers through the Platform.

Moxian+ Business App is an independent App with built in Social Customer Relationship Management tool built for merchants. Merchants are able to set up a store on the Moxian platform through this business App, push promotions via a variety of methods offered on the platform and look at generated report customized to their own shop.

Moxian's management team has more than 100 years of combined experience in a variety of pertinent endeavors, including management of private and public enterprise, multi-national organizations, quality, engineering and procurement, finance, marketing, communication and more. Together, Moxian's management team is effecting the company's aim to create and lead a personalized social network platform that best fits users and businesses. Disclaimer

Moxian, Inc. Company Blog

Moxian, Inc. News:

Moxian, Inc. to Ring in the Opening of NASDAQ Trade

Moxian, Inc. (Nasdaq: MOXC) to Ring The Nasdaq Stock Market Opening Bell

Moxian Adopts Oracle Database Solutions to Support the Latest Payment and Transaction Platform, Enabling Intelligent Big Data

Medical Transcription Billing, Corp. (MTBC)

The QualityStocks Daily Newsletter would like to spotlight Medical Transcription Billing, Corp. (MTBC). Today, Medical Transcription Billing, Corp. closed trading at $0.93, up 3.33%, on 2,200 volume with 2 trades. The stock’s average daily volume over the past 60 days is 13,552, and its 52-week low/high is $0.678/$1.50.

Medical Transcription Billing, Corp. (MTBC) is a healthcare information technology (IT) company that provides its fully integrated suite of proprietary web-based solutions and related business services to a diverse field of healthcare individuals and entities specializing in more than 63 areas and spanning 40 U.S. states.

The company went public in July 2014, at which time it also acquired three competitors. Since then, MTBC has steadily expanded its portfolio with seven additional acquisitions of competing healthcare IT companies, the most recent of which – and largest to-date - is Texas-based medical billing company, MediGain, LLC.

Today, MTBC is an award-winning company whose Software-as-a-Service (SaaS) platform helps healthcare providers increase revenues, fine tune their clinical and business decision making, reduce administrative burdens, streamline workflows, and reduce operating costs.

Its current products - electronic health records, practice management, patient engagement and the mHealth app – are fully integrated with core services that include medical billing services, value-added services, consultancy services, medical transcription, scribe services, and business intelligence. Notably, the standard fee for its comprehensive platform is calculated as a percentage of a practice's healthcare-related revenues, and is among the lowest in the industry.

MTBC is ranked among the Deloitte Technology Fast 500 (2009, 2010, 2011, 2012), is a Microsoft® Certified Partner, and has been awarded the Surescripts® White Coat of Quality, while its mHealth app – available for smartphone and tablet devices - is ranked No. 1 on Apple Store and Google Play as the most downloaded app for ICD 9 to ICD 10 conversion.

As a reputable IT provider for the healthcare industry, MTBC has built a client base of thousands of doctors. As a way of thanking them for their loyalty, MTBC recently launched its Client Loyalty Program in which it is awarding 100 shares of its publicly traded common stock to its providers and 1,000 shares for referring other physician practices. New MTBC clients are also eligible to participate and receive awards. Disclaimer

Medical Transcription Billing, Corp. Company Blog

Medical Transcription Billing, Corp. News:

MTBC Declares Monthly Dividends on Non-Convertible Series A Cumulative Redeemable Perpetual Preferred Stock Offering

MTBC Named in Deloitte's 2016 Technology Fast 500

MTBC Posts Q3 2016 Results; Discusses Quarterly Achievements

Net Element, Inc. (NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element, Inc. (NETE). Today, Net Element, Inc. closed trading at $0.9101, up 2.03%, on 75,495 volume with 134 trades. The stock’s average daily volume over the past 60 days is 438,430, and its 52-week low/high is $0.605/$4.60.

Net Element, Inc. (NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprises in the United States and select emerging markets. Leveraging a network of subsidiaries operating in the mobile payments and value-added transactional services space – including Unified Payments, Aptito and PayOnline – Net Element is committed to promoting consistent and strong growth, as illustrated by its position as one of the South Florida Business Journal's 'Top 25 Fastest-Growing Technology Companies'. In the first seven months of 2016 alone, the company realized a 77 percent year-over-year increase in transactional processing volume when discounting the effects of foreign currency exchange.

A major contributor to this sustained growth has been Net Element's PayOnline subsidiary, which offers state-of-the-art payment technologies that are currently employed by more than 3,000 online enterprises across Europe and Asia. To bolster this position, the company has continued to expand its presence in Central Asia, most recently through the opening of a new office in Kazakhstan, the largest country in the region. Since its first anchor project in Kazakhstan in June 2015, PayOnline has entered agreements with more than 180 online merchants in Central Asia, and the region is expected to offer an opportunity for tremendous growth in the coming years as the proliferation of electronic commerce takes hold.

The growth of PayOnline throughout Eurasia has been accompanied by both awards and industry recognition. Independent analytical agency Markswebb Rank & Report ranked PayOnline as a top five payment acceptance company in its 2016 Internet Acquiring Rank report, and a second analytical agency, Tagline.ru, ranked PayOnline as a leading payment gateway in its 2016 Payment Systems Rating. The company's management team attributes this success to PayOnline's "innovative, customer-focused products and services."

Net Element is led by a seasoned management team offering a unique blend of leadership, vision, experience and creative energy. Oleg Firer, the company's chief executive officer, formerly served as the executive chairman of Unified Payments up until its acquisition by Net Element's TOT Group in April 2013. Under his guidance, Unified Payments achieved rapid growth, earning the top spot on Inc. Magazine's list of fastest-growing companies in 2012. As a result, Firer was recognized by Forbes as one of the 'Five Incredible Entrepreneurs' and by Business Leader Magazine as a 'Top Entrepreneur in South Florida'. Disclaimer

Net Element, Inc. Company Blog

Net Element, Inc. News:

Net Element Partners with Mashreqbank in United Arab Emirates

Net Element Reports Third Quarter and Nine Months Ended September 30, 2016 Results Recent Highlights

Net Element Launches Proprietary Gift Card Software Application for Smart Payment Terminals

Monaker Group, Inc. (MKGI)

The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $2.75, up 1.85%, on 12,432 volume with 27 trades. The stock’s average daily volume over the past 60 days is 8,526, and its 52-week low/high is $1.10/$5.00.

Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.

NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.

Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.

Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.

In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.

With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.

Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer

Monaker Group, Inc. Company Blog

Monaker Group, Inc. News:

Monaker Groups Alternative Lodging Vacation Rentals Gain Exposure to Decision Makers at Over One Million Companies Worldwide

Monaker Group Achieves Key Milestone - Application Program Interface (API) and Booking Engine Complete

Monaker Launches Premium Service for Alternative Lodging Listings


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters





Small Cap Firm


Trader Power News

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251